BlossomHill Therapeutics, Inc.

US$13.50As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:BLSMHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap US$429.1M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$15
11.90%
(42.61%)
Hold 2|12|6|9|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.19
0.21
0.22
0.25
22.58%
17.45%
30.97%
33.51%
Revenue$M
28.15
28.69
28.13
29.81
7.24%
9.79%
4.42%
6.94%
Peers (US$429.1M)
Cap (US$)
PE
425.9M
18.15x
419.8M
—
Capital
TTM
5Y
10Y
Leveragex
0.560
(0.145)
(0.141)
EBIT/Intx
0.708
0.142
0.159
Own earn%
(21.19)
32.31
34.31
Sh yield%
29.31
33.36
34.67
Owners
Insiders/Inst%
5.11
71.80
Short interest%
5.30
SBC / revenue%
3.65
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
24–29
$1 testx
—
Incr. ROIC%
6